Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 18, 2014, 121 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.29 to $1,686,187,500.00.

Highlighted Stocks Traded by Insiders:

Jazz Pharmaceuticals (JAZZ) - FREE Research Report

Tobias Jeffrey K, who is EVP, Research & Dev and CMO at Jazz Pharmaceuticals, sold 1,000 shares at $173.32 on Nov. 18, 2014. Following this transaction, the EVP, Research & Dev and CMO owned 39,538 shares meaning that the stake was reduced by 2.47% with the 1,000-share transaction.

The shares most recently traded at $171.08, down $2.24, or 1.31% since the insider transaction. Historical insider transactions for Jazz Pharmaceuticals go as follows:

  • 4-Week # shares sold: 8,181
  • 12-Week # shares sold: 122,551
  • 24-Week # shares sold: 205,565

The average volume for Jazz Pharmaceuticals has been 821,400 shares per day over the past 30 days. Jazz Pharmaceuticals has a market cap of $10.3 billion and is part of the health care sector and drugs industry. Shares are up 33.92% year-to-date as of the close of trading on Tuesday.

Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. The company has a P/E ratio of 339.0. Currently, there are 10 analysts who rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JAZZ - FREE

TheStreet Quant Ratings rates Jazz Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and premium valuation. Get the full Jazz Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sovran Self Storage (SSS) - FREE Research Report

Killeen Edward F, who is EVP of Real Estate Management at Sovran Self Storage, sold 1,167 shares at $84.00 on Nov. 18, 2014. Following this transaction, the EVP of Real Estate Management owned 25,674 shares meaning that the stake was reduced by 4.35% with the 1,167-share transaction.

The shares most recently traded at $83.02, down $0.98, or 1.19% since the insider transaction. Historical insider transactions for Sovran Self Storage go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 8,702

The average volume for Sovran Self Storage has been 182,600 shares per day over the past 30 days. Sovran Self Storage has a market cap of $2.8 billion and is part of the financial sector and real estate industry. Shares are up 28.69% year-to-date as of the close of trading on Tuesday.

Sovran Self Storage, Inc. operates as a real estate investment trust (REIT). It engages in the acquisition, ownership, and management of self-storage properties in the United States. The stock currently has a dividend yield of 3.23%. The company has a P/E ratio of 33.3. Currently, there are 5 analysts who rate Sovran Self Storage a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SSS - FREE

TheStreet Quant Ratings rates Sovran Self Storage as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Sovran Self Storage Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Popeyes Louisiana Kitchen (PLKI) - FREE Research Report

Skehan Andrew G, who is COO, International at Popeyes Louisiana Kitchen, sold 5,000 shares at $51.86 on Nov. 18, 2014. Following this transaction, the COO, International owned 7,659 shares meaning that the stake was reduced by 39.5% with the 5,000-share transaction.

Cohen Harold M, who is General Counsel at Popeyes Louisiana Kitchen, sold 6,000 shares at $51.84 on Nov. 18, 2014. Following this transaction, the General Counsel owned 313 shares meaning that the stake was reduced by 95.04% with the 6,000-share transaction.

The shares most recently traded at $51.05, down $0.79, or 1.54% since the insider transaction. Historical insider transactions for Popeyes Louisiana Kitchen go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 10,165

The average volume for Popeyes Louisiana Kitchen has been 198,400 shares per day over the past 30 days. Popeyes Louisiana Kitchen has a market cap of $1.2 billion and is part of the services sector and leisure industry. Shares are up 33.77% year-to-date as of the close of trading on Tuesday.

Popeyes Louisiana Kitchen, Inc. develops, operates, and franchises quick-service restaurants. The company operates in two business segments, Franchise Operations and Company-Operated Restaurants. The company has a P/E ratio of 34.0. Currently, there are 4 analysts who rate Popeyes Louisiana Kitchen a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PLKI - FREE

TheStreet Quant Ratings rates Popeyes Louisiana Kitchen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Popeyes Louisiana Kitchen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null